Cristaloides y coloides en la reanimación del paciente crítico
…, JA Lorente, S Ruiz-Santana, A Artigas - Medicina intensiva, 2015 - Elsevier
La reanimación con fluidos es esencial para la supervivencia del paciente crítico en shock,
independientemente de la causa que lo origine. Hoy en día disponemos de diversos …
independientemente de la causa que lo origine. Hoy en día disponemos de diversos …
[HTML][HTML] Fragilidad en pacientes mayores de 65 años ingresados en cuidados intensivos (FRAIL-ICU)
…, NL Martín, MMI Jaimes, MI Villamayor, A Artigas… - Medicina Intensiva, 2019 - Elsevier
Objetivo Estimar la prevalencia de fragilidad en pacientes ingresados en cuidados intensivos
(UCI) y su impacto sobre la mortalidad intra UCI, al mes ya los 6 meses. Diseño Estudio …
(UCI) y su impacto sobre la mortalidad intra UCI, al mes ya los 6 meses. Diseño Estudio …
Biophysically preconditioning mesenchymal stem cells improves treatment of ventilator-induced lung injury
…, B Falcones, R Farre, A Artigas… - Archivos de …, 2020 - pubmed.ncbi.nlm.nih.gov
… 2 , Antonio Artigas …
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.
GR Bernard, A Artigas, KL Brigham, J Carlet… - American journal of …, 1994 - atsjournals.org
The acute respiratory distress syndrome (ARDS), a process of nonhydrostatic pulmonary
edema and hypoxemia associated with a variety of etiologies, carries a high morbidity, mortality …
edema and hypoxemia associated with a variety of etiologies, carries a high morbidity, mortality …
[HTML][HTML] The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
…, JC Marshall, J Bion, C Schorr, A Artigas… - Intensive care …, 2010 - Springer
Objective The Surviving Sepsis Campaign (SSC or “the Campaign”) developed guidelines
for management of severe sepsis and septic shock. A performance improvement initiative …
for management of severe sepsis and septic shock. A performance improvement initiative …
Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program
…, S Townsend, RP Dellinger, A Artigas… - Critical care …, 2014 - journals.lww.com
Objectives: Compelling evidence has shown that aggressive resuscitation bundles, adequate
source control, appropriate antibiotic therapy, and organ support are cornerstone for the …
source control, appropriate antibiotic therapy, and organ support are cornerstone for the …
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
…, H Burchardi, C Martin, S Goodman, A Artigas… - Intensive care …, 2002 - Springer
Objectives: To examine the incidence of infections and to describe them and their outcome
in intensive care unit (ICU) patients. Design and setting: International prospective cohort …
in intensive care unit (ICU) patients. Design and setting: International prospective cohort …
[HTML][HTML] Drotrecogin alfa (activated) in adults with septic shock
…, JC Marshall, A Rhodes, A Artigas… - … England Journal of …, 2012 - Mass Medical Soc
Background There have been conflicting reports on the efficacy of recombinant human
activated protein C, or drotrecogin alfa (activated) (DrotAA), for the treatment of patients with …
activated protein C, or drotrecogin alfa (activated) (DrotAA), for the treatment of patients with …
[HTML][HTML] Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
K Kashani, A Al-Khafaji, T Ardiles, A Artigas… - Critical care, 2013 - Springer
Introduction Acute kidney injury (AKI) can evolve quickly and clinical measures of function
often fail to detect AKI at a time when interventions are likely to provide benefit. Identifying …
often fail to detect AKI at a time when interventions are likely to provide benefit. Identifying …
[HTML][HTML] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial
…, C De Deyne, R Postier, V Pettilä, CL Sprung, A Artigas… - Jama, 2003 - jamanetwork.com
Context The expression and release of tissue factor is a major trigger for the activation of
coagulation in patients with sepsis. Tissue factor pathway inhibitor (TFPI) forms a complex with …
coagulation in patients with sepsis. Tissue factor pathway inhibitor (TFPI) forms a complex with …